{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:47:46Z","timestamp":1790362066112,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Swedish Research Council"},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stiftelsen Gamla Tj\u00e4narinnor"},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Torsten S\u00f6derberg Foundation"},{"name":"Swedish State Support for Clinical Research"},{"name":"Demensfonden and the UK Dementia Research Institute"},{"name":"Alzheimer\u2019s Research UK"},{"name":"Dementia research Institute"},{"name":"Reta Lila Weston Institute"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.neulet.2019.02.033","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T01:27:16Z","timestamp":1551058036000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"701","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-2836","authenticated-orcid":false,"given":"Eleni","family":"Gkanatsiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Portelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina E.","family":"Toomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Brinkmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neulet.2019.02.033_bib0005","first-page":"22","article-title":"Clinicopathologic studies of primary cerebral amyloid angiopathy","volume":"54","author":"Okazaki","year":"1979","journal-title":"Mayo Clin. Proc."},{"issue":"12","key":"10.1016\/j.neulet.2019.02.033_bib0010","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","article-title":"Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline","volume":"62","author":"Thal","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2019.02.033_bib0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","article-title":"Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy","volume":"110","author":"Attems","year":"2005","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.neulet.2019.02.033_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1532-5415.1981.tb01757.x","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"29","author":"Tomonaga","year":"1981","journal-title":"J. Am. Geriatr. Soc."},{"issue":"6","key":"10.1016\/j.neulet.2019.02.033_bib0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/01.STR.14.6.924","article-title":"Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes","volume":"14","author":"Vinters","year":"1983","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.neulet.2019.02.033_bib0030","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/WNL.58.11.1629","article-title":"Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study","volume":"58","author":"Pfeifer","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neulet.2019.02.033_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000180","article-title":"Epidemiological pathology of dementia: attributable-risks at death in the medical research council cognitive function and ageing study","volume":"6","author":"Matthews","year":"2009","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.neulet.2019.02.033_bib0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","article-title":"Two types of sporadic cerebral amyloid angiopathy","volume":"61","author":"Thal","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neulet.2019.02.033_bib0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.neulet.2019.02.033_bib0050","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/brain\/awx047","article-title":"Emerging concepts in sporadic cerebral amyloid angiopathy","volume":"140","author":"Charidimou","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neulet.2019.02.033_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","article-title":"Review: sporadic cerebral amyloid angiopathy","volume":"37","author":"Attems","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.neulet.2019.02.033_bib0060","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.neulet.2019.02.033_bib0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3233\/JAD-2001-3305","article-title":"Amyloid Abeta levels in Alzheimer's disease - A diagnostic tool and the key to understanding the natural history of Abeta?","volume":"3","author":"McLean","year":"2001","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neulet.2019.02.033_bib0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jnen\/61.3.254","article-title":"Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta","volume":"61","author":"Holton","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2019.02.033_bib0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9440(10)63993-4","article-title":"Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia","volume":"158","author":"Holton","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.neulet.2019.02.033_bib0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-009-0501-8","article-title":"Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies","volume":"118","author":"Revesz","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"20","key":"10.1016\/j.neulet.2019.02.033_bib0085","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neulet.2019.02.033_bib0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","article-title":"Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy","volume":"38","author":"Greenberg","year":"1995","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neulet.2019.02.033_bib0095","first-page":"2083","article-title":"Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer\u2019s disease","volume":"148","author":"Premkumar","year":"1996","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.neulet.2019.02.033_bib0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/acel.12045","article-title":"Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-beta from the mouse brain","volume":"12","author":"Hawkes","year":"2013","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.neulet.2019.02.033_bib0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-011-0801-7","article-title":"Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy","volume":"121","author":"Hawkes","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.neulet.2019.02.033_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041636","article-title":"Disruption of arterial perivascular drainage of amyloid-beta from the brains of mice expressing the human APOE epsilon4 allele","volume":"7","author":"Hawkes","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neulet.2019.02.033_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.neulet.2019.02.033_bib0120","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ana.410410607","article-title":"High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy","volume":"41","author":"Nicoll","year":"1997","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2019.02.033_bib0125","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.50.4.961","article-title":"Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy","volume":"50","author":"Greenberg","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neulet.2019.02.033_bib0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6393","key":"10.1016\/j.neulet.2019.02.033_bib0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/359325a0","article-title":"Isolation and quantification of soluble Alzheimer\u2019s beta-peptide from biological fluids","volume":"359","author":"Seubert","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neulet.2019.02.033_bib0140","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.neurobiolaging.2009.06.002","article-title":"A novel pathway for amyloid precursor protein processing","volume":"32","author":"Portelius","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.neulet.2019.02.033_bib0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1471-4159.2002.00985.x","article-title":"Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity","volume":"82","author":"Beher","year":"2002","journal-title":"J. Neurochem."},{"issue":"4959","key":"10.1016\/j.neulet.2019.02.033_bib0150","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.2111583","article-title":"Cleavage of amyloid beta peptide during constitutive processing of its precursor","volume":"248","author":"Esch","year":"1990","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.neulet.2019.02.033_bib0155","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","article-title":"Constitutive and regulated alpha-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by a disintegrin metalloprotease","volume":"96","author":"Lammich","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5054","key":"10.1016\/j.neulet.2019.02.033_bib0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neulet.2019.02.033_bib0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000369465","article-title":"Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer\u2019s disease by hybrid immunoprecipitation mass spectrometry","volume":"15","author":"Portelius","year":"2015","journal-title":"Neurodegener. Dis."},{"issue":"2","key":"10.1016\/j.neulet.2019.02.033_bib0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","article-title":"Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease","volume":"120","author":"Portelius","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neulet.2019.02.033_bib0175","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/s41598-018-21641-1","article-title":"Molecular subtypes of Alzheimer\u2019s disease","volume":"8","author":"Di Fede","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neulet.2019.02.033_bib0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2019.02.033_bib0185","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","author":"Blennow","year":"2018","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.neulet.2019.02.033_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ana.21694","article-title":"Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy","volume":"66","author":"Verbeek","year":"2009","journal-title":"Ann. Neurol."},{"issue":"82","key":"10.1016\/j.neulet.2019.02.033_bib0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.neulet.2019.02.033_bib0200","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neulet.2019.02.033_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.neulet.2019.02.033_bib0210","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/aww214","article-title":"Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment","volume":"139","author":"Skrobot","year":"2016","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neulet.2019.02.033_bib0215","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1212\/WNL.47.1.190","article-title":"The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer\u2019s disease and Lewy body variant","volume":"47","author":"Olichney","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neulet.2019.02.033_bib0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","article-title":"Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson\u2019s disease patients","volume":"115","author":"Lashley","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"Pt 9","key":"10.1016\/j.neulet.2019.02.033_bib0225","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1093\/brain\/awr160","article-title":"A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies","volume":"134","author":"Lashley","year":"2011","journal-title":"Brain"},{"issue":"5\u20136","key":"10.1016\/j.neulet.2019.02.033_bib0230","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000264639","article-title":"Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer\u2019s disease","volume":"6","author":"Portelius","year":"2009","journal-title":"Neurodegener. Dis."},{"issue":"11","key":"10.1016\/j.neulet.2019.02.033_bib0235","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1021\/pr0703627","article-title":"Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry","volume":"6","author":"Portelius","year":"2007","journal-title":"J. Proteome Res."},{"issue":"5","key":"10.1016\/j.neulet.2019.02.033_bib0240","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jms.2987","article-title":"An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid beta and amyloid precursor protein in human and cat cerebrospinal fluid","volume":"47","author":"Brinkmalm","year":"2012","journal-title":"J. Mass Spectrom."},{"issue":"4","key":"10.1016\/j.neulet.2019.02.033_bib0245","first-page":"1257","article-title":"Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer\u2019s disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene","volume":"148","author":"Mann","year":"1996","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.neulet.2019.02.033_bib0250","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.410300503","article-title":"Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study","volume":"30","author":"Vonsattel","year":"1991","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2019.02.033_bib0255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","article-title":"Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms","volume":"110","author":"Attems","year":"2005","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.neulet.2019.02.033_bib0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","article-title":"Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study","volume":"107","author":"Attems","year":"2004","journal-title":"Acta Neuropathol."},{"issue":"5\u20136","key":"10.1016\/j.neulet.2019.02.033_bib0265","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: an update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J. Neural Transm. Vienna (Vienna)"},{"issue":"1","key":"10.1016\/j.neulet.2019.02.033_bib0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.410240110","article-title":"Clinically diagnosed Alzheimer\u2019s disease: autopsy results in 150 cases","volume":"24","author":"Joachim","year":"1988","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.neulet.2019.02.033_bib0275","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.neurobiolaging.2008.01.017","article-title":"Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances","volume":"30","author":"Thal","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2019.02.033_bib0280","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2014.04.041","article-title":"The amyloid-beta degradation pattern in plasma--a possible tool for clinical trials in Alzheimer\u2019s disease","volume":"573","author":"Pannee","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2019.02.033_bib0285","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biochi.2015.03.022","article-title":"Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid","volume":"113","author":"Rogeberg","year":"2015","journal-title":"Biochimie"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019301259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019301259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:24:53Z","timestamp":1759609493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019301259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":57,"alternative-id":["S0304394019301259"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.02.033","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}